Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Zelda Therapeutics gains new strategic investor in Merchant Funds Management

Proactive Investors Tuesday, 11 June 2019
Zelda Therapeutics Ltd (ASX:ZLD) has gained a new strategic investor in leading boutique investment management group Merchant Funds Management which has obtained a 3.6% stake. This was facilitated by the sale by Zelda's founder and director Mara Gordon of 35.5 million shares, of which Merchant acquired 26,931,660. The sale by Gordon represented part of her holding in Zelda and she retains more than 44 million shares while remaining on the company's board. Zelda worked with CPS Capital Group to facilitate this investment by Merchant. READ: Zelda Therapeutics on rapid path to medicinal cannabis commercialisation The company's managing director Richard Hopkins said: “We are delighted to have secured Merchant as a strategic investor in Zelda and welcome their long-term support.” Merchant Funds managing director Andrew Chapman said: “Merchant was an early mover into the Australian medical cannabis sector and enjoys a long association with some of the founders of Zelda. “We believe Zelda has the potential to create significant shareholder value over the next 12 months as clinical trials complete and international commercialisation commences. “Developing novel intellectual property combined with a clear path to market is a valuable position to occupy in this rapidly expanding global industry.” READ: Zelda Therapeutics to use Federal Government R&D tax rebate of $769,000 to drive clinical trials Following this change in shareholding, the board of Zelda now holds a combined 204,222,646 shares representing 27% of issued capital and remains focused on growing shareholder value. On November 7, 2018, the board confirmed the commitment to not sell equity securities they own or control unless to help facilitate a major investment by a strategic investor. Zelda welcomes the support of Merchant who has a long and successful track record in the Australian medicinal cannabis sector.     Last month Hopkins presented at Proactive’s CEO Sessions in Sydney and Melbourne and told investors that the company was well placed to service a rapidly growing global market. He said the company was building a portfolio of clinically validated assets which presented multiple revenue opportunities to license as well as generate milestone and royalty payments. This strategy was well advanced because the company had a singular focus on clinical validation to address key unmet needs.
0
shares
ShareTweetSavePostSend
 
Credit: Wibbitz Studio - Published < > Embed
News video: 'The Legend of Zelda: Breath of the Wild' Is Getting a Sequel

'The Legend of Zelda: Breath of the Wild' Is Getting a Sequel 01:00

'The Legend of Zelda: Breath of the Wild' Is Getting a Sequel A short trailer was revealed by Nintendo at this year's E3 Expo. Since its release in March that year, over 14 million copies have been sold globally. The trailer for the sequel sees the protagonist Link and Princess Zelda exploring a...

Recent related videos from verified sources

Hoi-Polloi Groups Cut Out Sackler Family Over Opioid Crisis [Video]Hoi-Polloi Groups Cut Out Sackler Family Over Opioid Crisis

Business Insider reports many high-end non-profits, museums, and hedge funds have cut ties with the Sackler family. They include the Metropolitan Museum of New York, The National Portrait Gallery, and..

Credit: Wochit News     Duration: 00:47Published

Two News ETFs Perfect For the Risk Averse [Video]Two News ETFs Perfect For the Risk Averse

Innovator ETFs just launched two new products to be traded on the New York Stock Exchange, and the CEO and founder of the provider, Bruce Bond, broke down to TheStreet what the pitch to investors is. ..

Credit: The Street     Duration: 02:56Published


Recent related news from verified sources

Cuentas Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program

Cuentas Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
*MIAMI, FL / ACCESSWIRE / July 11, 2019 / *Cuentas, Inc. (OTCQB: CUEN), a leading FinTech provider of mobile banking and payment solutions serving Latino and...
Accesswire

Zelda Therapeutics responds to ASX query on price and volume increases

Zelda Therapeutics Ltd (ASX:ZLD) was queried by the ASX yesterday relating to the price of its securities, which went from a low of 4.6 cents at the close of...
Proactive Investors

Oliver Wyman and Corridor Platforms Announce Strategic Collaboration to Provide Industry-Leading Credit and Fraud Risk Management Solutions

NEW YORK--(BUSINESS WIRE)--Global management consulting firm Oliver Wyman and industry-leading risk management platform provider Corridor Platforms today...
Business Wire Also reported by •PR Newswire Asia

Australia: ASIC proposes to extend FFSP relief to 31 March 2020 and new funds management relief - Norton Rose Fulbright Australia

ASIC proposes licensing relief for foreign financial services providers of funds management services in Australia.
Mondaq Also reported by •bizjournals

You Might Like


Other recent news in Business

Strong U.S. RETAIL SALES boost economic outlookNetflix deletes SUICIDE SCENE from young adult show ‘13 Reasons Why’
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.